Gaslightwala Abizer (CIK 2049375) reported 12 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-08-29). Recent activity: Buy AKTX (10,000 shares), Buy AKTX (8,000 shares), Buy AKTX (3,000 shares), Buy AKTX (943 shares), Buy AKTX (5,203 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-08-29 | Akari Therapeutics Plc (AKTX) | CEO | Buy | 10,000 | $0 |
| 2025-08-29 | Akari Therapeutics Plc (AKTX) | CEO | Buy | 8,000 | $0 |
| 2025-08-29 | Akari Therapeutics Plc (AKTX) | CEO | Buy | 3,000 | $0 |
| 2025-06-25 | Akari Therapeutics Plc (AKTX) | President & CEO | Buy | 943 | $0 |
| 2025-06-25 | Akari Therapeutics Plc (AKTX) | President & CEO | Buy | 5,203 | $0 |
| 2025-06-24 | Akari Therapeutics Plc (AKTX) | President & CEO | Buy | 10,000 | $0 |
| 2025-06-20 | Akari Therapeutics Plc (AKTX) | President & CEO | Buy | 15,000 | $0 |
| 2025-06-16 | Akari Therapeutics Plc (AKTX) | CEO | Buy | 20,000 | $24,600 |
| 2025-06-16 | Akari Therapeutics Plc (AKTX) | CEO | Buy | 25,000 | $29,750 |
| 2025-06-12 | Akari Therapeutics Plc (AKTX) | CEO | Buy | 20,000 | $25,400 |
| 2025-03-10 | Akari Therapeutics Plc (AKTX) | Director | Buy | 133,928 | $149,999 |
| 2025-02-07 | Akari Therapeutics Plc (AKTX) | Director | Buy | 11,640 | $14,201 |
Source: SEC Form 4 filings · as of 2025-08-29